Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Daiichi Sankyo
Federal Trade Commission
Express Scripts
Fish and Richardson
Argus Health

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017783

« Back to Dashboard

NDA 017783 describes GLUCOTROL, which is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the GLUCOTROL profile page.

The generic ingredient in GLUCOTROL is glipizide. There are eighteen drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the glipizide profile page.

Summary for 017783

Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details

Pharmacology for NDA: 017783

Ingredient-typeSulfonylurea Compounds

Medical Subject Heading (MeSH) Categories for 017783

Suppliers and Packaging for NDA: 017783

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLUCOTROL glipizide TABLET;ORAL 017783 NDA Roerig 0049-4110 0049-4110-66 100 TABLET in 1 BOTTLE (0049-4110-66)
GLUCOTROL glipizide TABLET;ORAL 017783 NDA Roerig 0049-4120 0049-4120-66 100 TABLET in 1 BOTTLE (0049-4120-66)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:May 8, 1984TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:May 8, 1984TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2.5MG
Approval Date:May 11, 1993TE:RLD:No

Expired Orange Book Patents for NDA: 017783

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
PfizerGLUCOTROLglipizideTABLET;ORAL017783-001May 8, 1984► Subscribe► Subscribe
PfizerGLUCOTROLglipizideTABLET;ORAL017783-002May 8, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: